Savaria (TSE:SIS – Get Free Report) had its target price increased by research analysts at ATB Cormark Capital Markets from C$30.00 to C$32.00 in a note issued to investors on Friday,BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. ATB Cormark Capital Markets’ price target indicates a potential upside of 23.74% from the stock’s current price.
Other analysts have also issued reports about the company. Desjardins raised their price target on Savaria from C$27.00 to C$32.00 and gave the stock a “buy” rating in a research note on Friday. National Bank Financial boosted their target price on shares of Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a report on Friday. Raymond James Financial upped their price target on shares of Savaria from C$27.00 to C$32.00 and gave the stock an “outperform” rating in a research report on Friday. TD Securities lifted their price target on shares of Savaria from C$27.00 to C$31.00 and gave the company a “buy” rating in a report on Thursday. Finally, Stifel Nicolaus boosted their price objective on shares of Savaria from C$28.00 to C$29.00 and gave the company a “buy” rating in a research note on Friday. Seven equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of C$30.93.
View Our Latest Stock Analysis on SIS
Savaria Trading Down 2.1%
Savaria (TSE:SIS – Get Free Report) last released its earnings results on Wednesday, March 4th. The company reported C$0.37 EPS for the quarter. Savaria had a net margin of 6.90% and a return on equity of 10.24%. The firm had revenue of C$241.78 million during the quarter. As a group, analysts anticipate that Savaria will post 1.2048518 earnings per share for the current fiscal year.
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Articles
- Five stocks we like better than Savaria
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
